Pharmspective releases first knowledge management application: ClearView

Pharmspective, LLC today announced the release of its first knowledge management application - ClearView™ - specifically developed to analyze provisions in the health care reform law and their impact on key pharma customer decision makers who influence product adoption. Pharmspective, LLC is a Specialty Therapeutics market research firm providing knowledge management applications to the pharmaceutical industry.

Pharmspective's new ClearView™ PC and iPad-compatible web app is a subscription database housing over 400 key provisions of the health care reform legislation. The ClearView™ interactive platform will help Pharmspective subscribers assess the impact of key provisions of the legislation on pharmaceutical brands by providing up-to-date perspectives from published opinions and third-party points of view.

ClearView™: A Powerful Planning and Strategic Decision Making PlatformClearView™ is updated regularly with the most recent articles, interpretations, and potential commercial-impact scenarios related to the legislation.  The platform provides a number of distinct features:

• Description of key provisions
• Keyword search capability
• News Updates
• Scenario function – giving ClearView™ users the ability to input their own scenario assessments of key provisions in the legislation
• Report function
• Diagnostic Quiz for Corporate Training

"We're really proud of the cutting-edge user experience that our new ClearView™ app provides," said Karl Kessler, Chief Technology Officer. "ClearView™ translates the healthcare reform legislation through a dynamic, intuitive web app that lets the user browse and search the legislation, link to news articles and background material on the web, and collaborate with planning teams to assess and define the commercial impact of the law on pharma brands."

"The pharmaceutical industry is inundated with information about Healthcare Reform today and is in need of  solutions that navigate through its legislative complexity. We believe ClearView™ will be embraced as an invaluable planning tool that will facilitate thinking about how health care reform will impact the commercialization of pharma products today and in the future," stated Stephen Reid, Managing Partner and Co-Founder.